268 related articles for article (PubMed ID: 28714059)
41. Retroperitoneal kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon and obstructive jaundice: A retrospective series of 3 patients treated with sirolimus.
Yao W; Li K; Wang Z; Dong K; Zheng S
Pediatr Dermatol; 2020 Jul; 37(4):677-680. PubMed ID: 32212177
[TBL] [Abstract][Full Text] [Related]
42. Low dose sirolimus treatment for refractory tufted angioma and congenital kaposiform hemangioendothelioma, both with Kasabach-Merritt phenomenon.
Mariani LG; Schmitt IR; Garcia CD; Kiszewski AE
Pediatr Blood Cancer; 2019 Aug; 66(8):e27810. PubMed ID: 31087627
[No Abstract] [Full Text] [Related]
43. Successful treatment of Kasabach-Merritt syndrome arising from kaposiform hemangioendothelioma by systemic corticosteroid therapy and surgery.
Jiang RS; Hu R
Int J Clin Oncol; 2012 Oct; 17(5):512-6. PubMed ID: 21947597
[TBL] [Abstract][Full Text] [Related]
44. Consensus-derived practice standards plan for complicated Kaposiform hemangioendothelioma.
Drolet BA; Trenor CC; Brandão LR; Chiu YE; Chun RH; Dasgupta R; Garzon MC; Hammill AM; Johnson CM; Tlougan B; Blei F; David M; Elluru R; Frieden IJ; Friedlander SF; Iacobas I; Jensen JN; King DM; Lee MT; Nelson S; Patel M; Pope E; Powell J; Seefeldt M; Siegel DH; Kelly M; Adams DM
J Pediatr; 2013 Jul; 163(1):285-91. PubMed ID: 23796341
[No Abstract] [Full Text] [Related]
45. Anesthestic management of Kassabach-Meritt Phenomenon in an adult: case report.
Elkoundi A; Samali M; Kartite N; Tbouda M; Bensghir M; Haimeur C
BMC Anesthesiol; 2016 Nov; 16(1):109. PubMed ID: 27829366
[TBL] [Abstract][Full Text] [Related]
46. First report of oral atenolol for treatment of kaposiform hemangioendothelioma, a viable alternative to propranolol.
Yu L; Wei L; Ma L; Li L
J Dermatol; 2023 Apr; 50(4):e123-e124. PubMed ID: 36495080
[No Abstract] [Full Text] [Related]
47. Sirolimus as initial therapy for kaposiform hemangioendothelioma and tufted angioma.
Wang H; Guo X; Duan Y; Zheng B; Gao Y
Pediatr Dermatol; 2018 Sep; 35(5):635-638. PubMed ID: 29999213
[TBL] [Abstract][Full Text] [Related]
48. Kaposiform hemangioendothelioma with Kasabach-Merritt syndrome: successful treatment with sirolimus.
Reichel A; Hamm H; Wiegering V; Wiewrodt B; Neubauer H; Ernestus K; Winkler B
J Dtsch Dermatol Ges; 2017 Mar; 15(3):329-331. PubMed ID: 28220608
[No Abstract] [Full Text] [Related]
49. Successful treatment of Kaposiform hemangioendothelioma with everolimus.
Uno T; Ito S; Nakazawa A; Miyazaki O; Mori T; Terashima K
Pediatr Blood Cancer; 2015 Mar; 62(3):536-8. PubMed ID: 25306933
[TBL] [Abstract][Full Text] [Related]
50. Effective low-dose sirolimus regimen for kaposiform haemangioendothelioma with Kasabach-Merritt phenomenon in young infants.
Harbers VEM; van der Salm N; Pegge SAH; van der Vleuten CJM; Verhoeven BH; Vrancken SLAG; Schultze Kool LJ; Fuijkschot J; Te Loo DMMWM
Br J Clin Pharmacol; 2022 Jun; 88(6):2769-2781. PubMed ID: 34957601
[TBL] [Abstract][Full Text] [Related]
51. Giant retroperitoneal Kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon: A case report.
Wu D; Xu J; Wang P; Zhou S
Asian J Surg; 2023 Feb; 46(2):1014-1015. PubMed ID: 35961905
[No Abstract] [Full Text] [Related]
52. Kaposiform hemangioendothelioma in an adult with rheumatoid arthritis.
Filotico M; Filotico R
Pathologica; 2017 Sep; 109(3):143-147. PubMed ID: 29154372
[TBL] [Abstract][Full Text] [Related]
53. A kaposiform haemangioendothelioma successfully treated with topical tacrolimus and compression bandaging.
Nic Dhonncha E; Sadlier M
Clin Exp Dermatol; 2022 Oct; 47(10):1870-1871. PubMed ID: 35700108
[TBL] [Abstract][Full Text] [Related]
54. Association between extremity kaposiform hemangioendothelioma and lymphedema.
Konczyk DJ; Goss JA; Maclellan RA; Greene AK
Pediatr Dermatol; 2018 Jan; 35(1):e92-e93. PubMed ID: 29266383
[TBL] [Abstract][Full Text] [Related]
55. Successful Management of Pancreatic Kaposiform Hemangioendothelioma With Sirolimus: Case Report and Literature Review.
Wang C; Li Y; Xiang B; Li F; Chen S; Li L; Ji Y
Pancreas; 2017; 46(5):e39-e41. PubMed ID: 28426496
[No Abstract] [Full Text] [Related]
56. NEWBORNS WITH KASABACH-MERRITT PHENOMENON-ASSOCIATED KAPOSIFORM HEMANGIOENDOTHELIOMA: A REPORT OF 6 CASES.
Benzar IM; Rebenkov SO; Levytskyi AF; Fedoniuk LY; Fomina LV; Sas LM; Stravskyy TY
Wiad Lek; 2020; 73(8):1785-1789. PubMed ID: 33055352
[TBL] [Abstract][Full Text] [Related]
57. Recurrent multifocal cutaneous Kaposiform hemangioendothelioma: A rare vascular tumor of infancy and childhood.
Atla B; Sudhakar PV; Rao N; Prasad U
Indian J Pathol Microbiol; 2016; 59(3):392-4. PubMed ID: 27510687
[TBL] [Abstract][Full Text] [Related]
58. Kaposiform Hemangioendothelioma with Kasabach-Merritt Phenomenon.
Pati S; Das MK; Rana A; Das E; Sarkar S; Sherpa N; Datta S
Indian J Pediatr; 2021 Nov; 88(11):1142-1144. PubMed ID: 34106442
[TBL] [Abstract][Full Text] [Related]
59. Kaposiform haemangioendothelioma: a review with emphasis on histological differential diagnosis.
Putra J; Gupta A
Pathology; 2017 Jun; 49(4):356-362. PubMed ID: 28438388
[TBL] [Abstract][Full Text] [Related]
60. Successful Propranolol Treatment of a Kaposiform Hemangioendothelioma Apparently Resistant to Propranolol.
Filippi L; Tamburini A; Berti E; Perrone A; Defilippi C; Favre C; Calvani M; Della Bona ML; la Marca G; Donzelli G
Pediatr Blood Cancer; 2016 Jul; 63(7):1290-2. PubMed ID: 27100060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
